Baseline and demographic characteristics | All patients (n = 1003) |
---|---|
Age at index date, years, mean (SD) | 39.7 (12.4) |
Sex, n (%) | |
 Female | 760 (75.8) |
 Male | 241 (24.0) |
 Other | 2 (0.2) |
Race, n (%) | |
 White | 782 (78.0) |
 Black or African American | 137 (13.7) |
 Asian | 56 (5.6) |
 Native American or American Indian | 7 (0.7) |
 Other | 20 (2.0) |
 Unknown | 1 (0.1) |
Migraine diagnosis, n (%) | |
 CM | 587 (58.5) |
 EM | 416 (41.5) |
Duration of follow-up (months), mean (SD) | 7.1 (4.4) |
Time from date of diagnosis to index date (years), mean (SD) | 6.6 (8.5) |
Number of prior treatment failures, n (%) | |
 0 | 60 (6.0) |
 1 | 111 (11.1) |
  ≥ 2 | 832 (82.9) |
Baseline MMD, mean (SD) | 12.7 (6.4) |
Baseline MHD, mean (SD) | 14.0 (8.0) |
Baseline HIT-6 score, mean (SD) | 60.0 (8.9) |
Baseline MIDAS score, mean (SD) | 28.7 (28.5) |
Comorbid conditions at baseline, n (%)a | |
 Insomnia | 196 (19.5) |
 Allergies | 158 (15.8) |
 Neck pain | 155 (15.5) |
 Hypertension | 143 (14.3) |
 Back pain | 138 (13.8) |
 Obesity | 137 (13.7) |
 MDD | 134 (13.4) |
 GAD | 120 (12.0) |
 Chronic pain | 111 (11.1) |
 Asthma | 101 (10.1) |
 Fibromyalgia | 96 (9.6) |
 High cholesterol | 94 (9.4) |
 Gastroesophageal reflux | 80 (8.0) |
 Other anxiety (non-GAD) | 60 (6.0) |
 Sinusitis | 52 (5.2) |